Showing 501-510 of 7525 results for "".
The Future of Telemedicine in Aesthetics
https://practicaldermatology.com/topics/practice-management/the-future-of-telemedicine-in-aesthetics/21073/What are promises and pitfalls of remote medical consultation and care delivery in aesthetics?Dr. Simpson Highlights Potentially Remittive Anti-OX40s at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/dr-simpson-highlights-potentially-remittive-anti-ox40s-at-maui-derm/32920/Two anti-OX40 drugs in the pipeline may have remittive properties for atopic dermatitis, according to Eric Simpson, MD.SDPA: Medical Director Dr. Hilary Baldwin Discusses Acne and Keloids Lectures
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-discusses-acne-and-keloids-lectures/29508/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. She explains the key takeaways of her lectures on acne and keloids.SDPA: Dr. Matthew Zirwas Discusses Benefits of Attending the Annual Conference
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-dr-matthew-zirwas-discusses-benefits-of-attending-the-annual-conference/29510/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Matthew Zirwas, MD. Dr. Zirwas shares why he looks forward to lecturing at the annual meeting.FDA Approves Bimzelx for Hidradenitis Suppurativa
https://practicaldermatology.com/series/dermwire-tv/fda-approves-bimzelx-hidradenitis-suppurativa/29518/In this week's DermwireTV, the FDA approves a new treatment for moderate to severe hidradenitis suppurativa; the FDA agrees to review the resubmission of Dupixent for the treatment of CSU; and the president of Merz Aesthetics, North America, joins us to discuss trends in the aesthetic market.FDA Approves Rosacea Treatment Emrosi
https://practicaldermatology.com/series/dermwire-tv/fda-approves-rosacea-treatment-emrosi/29207/In this week's DermwireTV, the FDA approves a first-of-its-kind treatment for rosacea in adults; two companies with approved atopic dermatitis products provide new long-term efficacy and safety data; and Andrew Mastro discusses how to recognize physician burnout.Understanding Disparities in AD
https://practicaldermatology.com/series/updates-atopic-dermatitis/understanding-disparities-ad/29081/Dr. Raj Chovatiya, Clinical Associate Professor of Medicine at Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology and Immunology Research, talks with Practical Dermatology about understanding disparities in atopic dermatitis and the socHow to Approach a Contract Negotiation
https://practicaldermatology.com/series/pa-perspectives/how-approach-contract-negotiation/29072/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, provides tips on how to approach a contract negotiation, including the importance of using objective data while negotiating.Innovative Techniques for Forehead Wrinkles, Acne Laser Treatment, and More
https://practicaldermatology.com/conferences/maui-derm-2024/innovative-techniques-for-forehead-wrinkles-acne-laser-treatment-and-more/20250/Valerie D. Callender, MD, discusses the 3 cases she presented at Maui Derm 2024: filling in deeply etched forehead wrinkles with a resilient hyaluronic acid filler, treating acne with the 1726 nanometer laser, and treating melasma with a triple-combo procedure that includes maintenance therapy.Preventing AD in High-Risk Infants
https://practicaldermatology.com/topics/atopic-dermatitis/preventing-ad-in-high-risk-infants/20223/Early initiation of short-term emollient use, especially one that contains colloidal oatmeal, can improve skin barrier function and slash the chances of developing atopic dermatitis in high-risk infants. Paul Horowitz, MD, a pediatrician in Valencia, CA, shares highlights from his talk on the STOP-A